Obesity is directly related to the development of cardiometabolic disease (arterial hypertension, coronaric syndrome or heart failure (10) and in particular abdominal obesity is the most frequent component of metabolic syndrome along with T2D, dyslipidemia and hypertension (1113)
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49)
Long-term success is defined by an improved quality of life and the ability to enjoy daily activities rather than just the number on a scale
While formulations differ in dosing frequency, onset, and tolerability, they show broadly comparable safety and efficacy
These findings are consistent with data accessed on January 2, 2024
6 But this still doesnt tell us why GLP-1s are so versatile